Elite Pharmaceuticals Inc ELTP:OTCQB

RT Quote | Exchange | USD
Last | 05/07/21 EDT
0.061quote price arrow up+0.0012 (+2.01%)
Volume
1,052,868
52 week range
0.05 - 0.10

...

Loading . . .
  • Open0.058
  • Day High0.061
  • Day Low0.058
  • Prev Close0.0598
  • 52 Week High0.10
  • 52 Week High Date06/30/20
  • 52 Week Low0.05
  • 52 Week Low Date11/30/20

Key Stats

  • Market Cap61.57M
  • Shares Out1.009B
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.64
  • YTD % Change16.97

KEY STATS

  • Open0.058
  • Day High0.061
  • Day Low0.058
  • Prev Close0.0598
  • 52 Week High0.10
  • 52 Week High Date06/30/20
  • 52 Week Low0.05
  • 52 Week Low Date11/30/20
  • Market Cap61.57M
  • Shares Out1.009B
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.64
  • YTD % Change16.97

RATIOS/PROFITABILITY

  • EPS (TTM)0.01
  • P/E (TTM)10.48
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)3.115M
  • ROE (MRQ)110.23%
  • Revenue (MRQ)25.93M
  • Gross Margin (MRQ)48.05%
  • Net Margin (MRQ)25.10%
  • Debt To Equity (MRQ)26.74%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Elite Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is principally engaged in the development and manufacture of oral, controlled-release products. The Company develops and manufactures generic products, products using controlled-release drug technology, products utilizing abuse deterrent technologies, and it develops and markets generic controlled-release and abuse deterrent pharmaceutical products. Its segments include Abbreviated New Drug...
Nasrat Hakim
Chairman
Douglas Plassche
Executive Vice President
Jason LePree
Vice President
Address
165 Ludlow Ave
Northvale, NJ
07647-2305
United States

Top Peers

SYMBOLLASTCHG%CHG
BXRX
Baudax Bio Inc
0.8831+0.0516+6.21%
ARPO
Aerpio Pharmaceuticals Inc
1.05UNCHUNCH
GTBP
GT Biopharma Inc
16.55+0.46+2.86%
ACUR
Acura Pharmaceuticals Inc
0.38-0.02-5.00%
PRPH
Prophase Labs Inc
5.53-0.07-1.25%
ADMP
Adamis Pharmaceuticals Corp
0.7453+0.0081+1.10%